Our study found 18 out of 25 patients with PAFAH1B1 deletions or intragenic variations showed lissencephaly in their MRI tests, and the lissencephaly severity were independent of the extent of deletion. This evidence concerns the gene PAFAH1B1 and lissencephaly spectrum disorders.